SCHEMBL22726599

SCHEMBL22726599

CC(C)(C)OC(=O)N1CCCC1c1ccnc(N)c1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ UCHL1 P09936 1/20 0.52
▸ ROCK2 O75116 1/20 0.49
▸ ALDH1A1 P00352 4/20 0.43
▸ RIPK1 Q13546 2/20 0.43
▸ LMNA P02545 4/20 0.43
▸ NPSR1 Q6W5P4 3/20 0.43
▸ TSHR P16473 5/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ HTT P42858 1/20 0.41
▸ ALOX5AP P20292 1/20 0.41
▸ FEN1 P39748 1/20 0.41
▸ POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29953798 1.00 UCHL1 (0.52) UCHL1ROCK2ALDH1A1RIPK1LMNA
SCHEMBL17151081 0.87 LMNA (0.46) UCHL1ALDH1A1RIPK1LMNANPSR1
SCHEMBL14240400 0.86 ALDH1A1 (0.43) UCHL1ALDH1A1RIPK1LMNANPSR1
SCHEMBL30745375 0.85 ALDH1A1 (0.45) UCHL1ALDH1A1RIPK1LMNANPSR1
SCHEMBL22726571 0.84 UCHL1 (0.41) UCHL1ROCK2
SCHEMBL29953613 0.84 UCHL1 (0.41) UCHL1ROCK2
SCHEMBL22473361 0.83 PRMT5 (0.43) UCHL1ALDH1A1RIPK1LMNANPSR1
SCHEMBL30620837 0.82 ALOX5AP (0.46) UCHL1ALDH1A1RIPK1LMNANPSR1
SCHEMBL21198773 0.81 RIPK1 (0.53) UCHL1ALDH1A1RIPK1LMNANPSR1
SCHEMBL31226555 0.81 RIPK1 (0.53) UCHL1ALDH1A1RIPK1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976189-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES GALAPAGOS NV (BE) 2024-07-03 — — EP disclosed
WO-2020239658-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES GALAPAGOS NV (BE) 2020-12-03 — — WO disclosed
Send feedback